{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:37:19Z","timestamp":1769607439063,"version":"3.49.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:00:00Z","timestamp":1493164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:00:00Z","timestamp":1493164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100001424","name":"American Liver Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001424","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1111\/bjd.15170","type":"journal-article","created":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T19:45:41Z","timestamp":1479152741000},"page":"1492-1499","source":"Crossref","is-referenced-by-count":37,"title":["Methotrexate treatment and risk for cutaneous malignant melanoma: a retrospective comparative registry-based cohort study"],"prefix":"10.1093","volume":"176","author":[{"given":"S.","family":"Polesie","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology; Sahlgrenska University Hospital; Institute of Clinical Sciences at the Sahlgrenska Academy; University of Gothenburg; Gothenburg Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gillstedt","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology; Sahlgrenska University Hospital; Institute of Clinical Sciences at the Sahlgrenska Academy; University of Gothenburg; Gothenburg Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.H.","family":"S\u00f6nnergren","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology; Sk\u00e5ne University Hospital; Lund Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Osmancevic","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology; Sahlgrenska University Hospital; Institute of Clinical Sciences at the Sahlgrenska Academy; University of Gothenburg; Gothenburg Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Paoli","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology; Sahlgrenska University Hospital; Institute of Clinical Sciences at the Sahlgrenska Academy; University of Gothenburg; Gothenburg Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,4,26]]},"reference":[{"key":"10.1111\/bjd.15170-BIB0001|bjd15170-cit-0001","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/ar419","article-title":"Molecular action of methotrexate in inflammatory diseases","volume":"4","author":"Chan","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1111\/bjd.15170-BIB0002|bjd15170-cit-0002","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0889-857X(05)70368-9","article-title":"Does methotrexate increase the risk of infection or malignancy?","volume":"23","author":"Kanik","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1111\/bjd.15170-BIB0003|bjd15170-cit-0003","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/art.23716","article-title":"Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate","volume":"59","author":"Buchbinder","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/bjd.15170-BIB0004|bjd15170-cit-0004","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000249793","article-title":"Frequency of malignant neoplasms in 248 long-term methotrexate-treated psoriatics. A preliminary study","volume":"167","author":"Nyfors","year":"1983","journal-title":"Dermatologica"},{"key":"10.1111\/bjd.15170-BIB0005|bjd15170-cit-0005","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/1097-0142(19820901)50:5<869::AID-CNCR2820500511>3.0.CO;2-V","article-title":"Methotrexate used for psoriasis and the risk of noncutaneous or cutaneous malignancy","volume":"50","author":"Stern","year":"1982","journal-title":"Cancer"},{"key":"10.1111\/bjd.15170-BIB0006|bjd15170-cit-0006","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jama.1975.03250040013017","article-title":"Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysis","volume":"232","author":"Bailin","year":"1975","journal-title":"JAMA"},{"key":"10.1111\/bjd.15170-BIB0007|bjd15170-cit-0007","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/jid.2008.423","article-title":"Increasing burden of melanoma in the United States","volume":"129","author":"Linos","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.15170-BIB0008|bjd15170-cit-0008","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3322\/caac.20074","article-title":"The evolution of melanoma diagnosis: 25 years beyond the ABCDs","volume":"60","author":"Rigel","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1111\/bjd.15170-BIB0009|bjd15170-cit-0009","unstructured":"Socialstyrelsen National Board of Health and Welfare: The Prescribed Drug Register www.nepi.net\/Socialstyrelsens-laekemedelsregister.htm"},{"key":"10.1111\/bjd.15170-BIB0010|bjd15170-cit-0010","unstructured":"Socialstyrelsen National Board of Health and Welfare: The Swedish Cancer Registry Register www.socialstyrelsen.se\/register\/halsodataregister\/cancerregistret"},{"key":"10.1111\/bjd.15170-BIB0011|bjd15170-cit-0011","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00484-011-0474-x","article-title":"Fifty years of changes in UV index and implications for skin cancer in Australia","volume":"56","author":"Lemus-Deschamps","year":"2012","journal-title":"Int J Biometeorol"},{"key":"10.1111\/bjd.15170-BIB0012|bjd15170-cit-0012","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ijc.27616","article-title":"International trends in the incidence of malignant melanoma 1953-2008 - are recent generations at higher or lower risk?","volume":"132","author":"Erdmann","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1111\/bjd.15170-BIB0013|bjd15170-cit-0013","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/rheumatology\/kew214","article-title":"Disease-modifying anti-rheumatic drugs and non-melanoma skin cancer in inflammatory arthritis patients: a retrospective cohort study","volume":"55","author":"Lange","year":"2016","journal-title":"Rheumatology"},{"key":"10.1111\/bjd.15170-BIB0014|bjd15170-cit-0014","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","article-title":"Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis","volume":"17","author":"Simon","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/bjd.15170-BIB0015|bjd15170-cit-0015","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/art.27402","article-title":"Do rheumatoid arthritis and lymphoma share risk factors?: a comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis","volume":"62","author":"Hellgren","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1111\/bjd.15170-BIB0016|bjd15170-cit-0016","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1046\/j.0022-202x.2001.01520.x","article-title":"Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden","volume":"117","author":"Boffetta","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.15170-BIB0017|bjd15170-cit-0017","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/sj.bjc.6605027","article-title":"Cancer risk in hospitalised psoriasis patients: a follow-up study in Sweden","volume":"100","author":"Ji","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1111\/bjd.15170-BIB0018|bjd15170-cit-0018","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/jamadermatol.2015.4847","article-title":"The risk of cancer in patients with psoriasis: a population-based cohort study in the health improvement network","volume":"152","author":"Chiesa Fuxench","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1111\/bjd.15170-BIB0019|bjd15170-cit-0019","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jdv.12949","article-title":"Co-existence of psoriasis and melanoma in a large urban academic centre population: a cross-sectional retrospective study","volume":"30","author":"Bhattacharya","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.15170-BIB0020|bjd15170-cit-0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1684\/ejd.2014.2501","article-title":"Reduced frequency of melanoma in 72,739 patients with psoriasis: a retrospective study","volume":"25","author":"Paradisi","year":"2015","journal-title":"Eur J Dermatol"},{"key":"10.1111\/bjd.15170-BIB0021|bjd15170-cit-0021","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/jdv.13619","article-title":"Skin cancer in patients with psoriasis","volume":"30","author":"Egeberg","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.15170-BIB0022|bjd15170-cit-0022","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.abb.2014.04.019","article-title":"Methotrexate inhibits the viability of human melanoma cell lines and enhances Fas\/Fas-ligand expression, apoptosis and response to interferon-alpha: rationale for its use in combination therapy","volume":"563","author":"Nihal","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"10.1111\/bjd.15170-BIB0023|bjd15170-cit-0023","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature15726","article-title":"Oxidative stress inhibits distant metastasis by human melanoma cells","volume":"527","author":"Piskounova","year":"2015","journal-title":"Nature"},{"key":"10.1111\/bjd.15170-BIB0024|bjd15170-cit-0024","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2340\/00015555-1753","article-title":"The risk of skin cancer in psoriasis patients treated with UVB therapy","volume":"94","author":"Osmancevic","year":"2014","journal-title":"Acta Dermato-Venereol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.15170","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.15170","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.15170\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:24:27Z","timestamp":1676384667000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/176\/6\/1492\/6687248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,26]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.15170","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4,26]]}}}